Table 1.
Study | Data Source | Dates | Case Definition | # GP Studied | # At Risk Population | Estimates and Major Findings |
---|---|---|---|---|---|---|
| ||||||
Community | ||||||
Jung, et al. 2009 | Rochester Epidemiology Project | 1996 – 2006 | ICD codes, objective tests, and Sx | 222 | 124,277 | Prevalence: men and women 9.6 and 37.8 (average 24.2) per 100,000 persons; Incidence: men and women 2.5 and 9.8 (average 6.3) per 100,000 person-years, respectively¥ |
Syed, et al. 2020 | Explorys | 1999 – 2014 | ICD-9 code | 69,950 | 43,827,910 | Prevalence overall 159.6 per 100,000 persons; T1D and T2D prevalence was 4.59% and 1.31%, respectively |
Ye, et al. 2021 (UK) | UK Clinical Practice Research Datalink | 2000 – 2016 | Chart diagnosis | 1,135 | 11,576,068 | Prevalence 13.8 per 100,000 persons; incidence 1.9 per 100,000 person-years; 39.4% idiopathic, 37.5% diabetic¥ |
Ye, et al. 2022 (USA) | Optum Clinformatics Data Mart | 2000 – 2019 | ICD codes, objective tests, and Sx | 71,775 | 82,574,650 | Overall prevalence of GP 267.7 per 100,000; “definite” GP: 21.5 per 100,000 persons; female predominance; 57.4% diabetic, 15% post-surgical, 11.8% drug-induced, 11.3% idiopathic¥ |
Inpatient/Emergency Department | ||||||
Bell, et al. 2002 § | NC Hospital Discharge Database | 1998 | ICD-9 code | 1,476 | NA | Of all GP discharges, 38.9% had diabetic GP; mortality among diabetic GP 0.6%; female predominance |
Bielefeldt 2013 | State Inpatient Database | 2007 – 2010 | ICD-9 code | NA* | NA | Fewest and greatest inpatient admissions in Utah and Maryland, respectively; mortality estimate 0.5 to 2.3 per 100,000 persons† |
Hirsch, et al. 2019 | National ED Sample | 2006 – 2013 | ICD-9 code | 203,248 | 240 millionΩ | ED visits increased from 12.9 to 27.3 per 100,000 visits; among diabetic GP, visits increased by 148%; female predominance |
Kichloo, et al. 2021 | 2016 – 2017 | ICD-10 code | 99,695 | > 71 millionα | 78.1% with diabetic GP; overall inpatient mortality estimate 0.25%; non-diabetic GP more common in white race | |
Nusrat, et al. 2013 | Nationwide Inpatient Sample | 1994 – 2009 | ICD-9 code | 129,578Δ | NA | Hospitalizations for primarily GP increased 18-fold while FGIDs decreased by half; female predominance |
Wadhwa, et al. 2017 | 1997 – 2013 | ICD-9 code | 150,532Δ | NA | Discharge diagnoses overall increased 4-fold¥; female predominance; among T1D and T2D there was 6- and 3.7-fold increases, respectively | |
Wang, et al. 2008 | 1995 – 2004 | ICD-9 code | 60,895 | 361,768,699 | Hospitalizations with GP as primary and secondary diagnosis increased 2.5- and 2.4-fold, respectively | |
Diabetes Mellitus | ||||||
Aleppo, et al. 2017 | T1D Exchange Registry | 2010 – 2012 | Chart diagnosis | 340 | 7,107 | 4.8% prevalence among persons with T1D; female predominance |
Choung, et al. 2012 | Rochester Epidemiology Project | 1996 – 2006 | ICD codes, objective tests, and Sx | 15 | 227 T1D, 360 T2D, 639 controls | Incidence of GP over 10 years: 5.2% in T1D, 1.0% in T2D, and 0.2% in controls |
Study estimates were limited to patients with concurrent diagnosis of diabetes based on the medical record.
Admissions for GP ranged from 24.3 to 117.1 per 100,000 persons (normalized to state 2010 census data).
Estimates standardized to state populations based on 2010 census data.
Number obtained by estimating values from graphical figures using the WebPlotDigitizer, version 4.5 (https://apps.automeris.io/wpd/), accessed April 10, 2022.
Estimated as NEDS captures about 30 million ED visits per year.
Exact number not provided.
Prevalence and incidence estimates were, at minimum, age-adjusted/standardized to the population.
ED, Emergency Department; FGID, functional gastrointestinal disorders; GP, gastroparesis; ICD, International Classification of Diseases; NA, not available; NC, North Caroline; Sx, symptoms; T1D, type 1 diabetes mellitus; T2D, type 2 diabetes mellitus; UK, United Kingdom; USA, United States of America.